South Asia: In South Asia, India leads the demand for GLP-1 receptor agonists, supported by a large diabetic patient population and increasing healthcare access
This page is educational only and does not provide a prescription, dosing recommendation, diagnosis, or treatment plan
Expected Results (Realistic Timeline) Your results will depend on your diet, lifestyle, and physical activity levels
The DermaVue Clinics medical team prescribes semaglutide (Ozempic and Wegovy) for South Asian patients within a structured weight management protocol that includes weekly dose titration from 0.25 mg to 2.4 mg, monthly metabolic and renal review, and a 1.2 to 1.6 g/kg protein target to preserve lean mass
This eligibility is aligned with guidelines for chronic weight management therapies
Taking medication that helps lower cholesterol Lifestyle changes on their own might not be enough to lower your cholesterol